Literature DB >> 15746444

Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study.

Arne Pfeufer1, Shapour Jalilzadeh, Siegfried Perz, Jakob C Mueller, Martin Hinterseer, Thomas Illig, Mahmut Akyol, Cornelia Huth, Andreas Schöpfer-Wendels, Bernhard Kuch, Gerhard Steinbeck, Rolf Holle, Michael Näbauer, H-Erich Wichmann, Thomas Meitinger, Stefan Kääb.   

Abstract

Altered myocardial repolarization is one of the important substrates of ventricular tachycardia and fibrillation. The influence of rare gene variants on repolarization is evident in familial long QT syndrome. To investigate the influence of common gene variants on the QT interval we performed a linkage disequilibrium based SNP association study of four candidate genes. Using a two-step design we analyzed 174 SNPs from the KCNQ1, KCNH2, KCNE1, and KCNE2 genes in 689 individuals from the population-based KORA study and 14 SNPs with results suggestive of association in a confirmatory sample of 3277 individuals from the same survey. We detected association to a gene variant in intron 1 of the KCNQ1 gene (rs757092, +1.7 ms/allele, P=0.0002) and observed weaker association to a variant upstream of the KCNE1 gene (rs727957, +1.2 ms/allele, P=0.0051). In addition we detected association to two SNPs in the KCNH2 gene, the previously described K897T variant (rs1805123, -1.9 ms/allele, P=0.0006) and a gene variant that tags a different haplotype in the same block (rs3815459, +1.7 ms/allele, P=0.0004). The analysis of additive effects by an allelic score explained a 10.5 ms difference in corrected QT interval length between extreme score groups and 0.951 of trait variance (P<0.00005). These results confirm previous heritability studies indicating that repolarization is a complex trait with a significant heritable component and demonstrate that high-resolution SNP-mapping in large population samples can detect and fine map quantitative trait loci even if locus specific heritabilities are small.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746444     DOI: 10.1161/01.RES.0000161077.53751.e6

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  51 in total

1.  Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.

Authors:  Alon Barsheshet; Arthur J Moss; Scott McNitt; Slava Polonsky; Coeli M Lopes; Wojciech Zareba; Jennifer L Robinson; Michael J Ackerman; Jesaia Benhorin; Elizabeth S Kaufman; Jeffrey A Towbin; G Michael Vincent; Ming Qi; Ilan Goldenberg
Journal:  Circ Cardiovasc Genet       Date:  2011-08-10

Review 2.  Drug- and non-drug-associated QT interval prolongation.

Authors:  Charlotte van Noord; Mark Eijgelsheim; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

Review 3.  Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Authors:  Russell A Wilke; Debbie W Lin; Dan M Roden; Paul B Watkins; David Flockhart; Issam Zineh; Kathleen M Giacomini; Ronald M Krauss
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

4.  Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects.

Authors:  L Gouas; V Nicaud; S Chaouch; M Berthet; A Forhan; J Tichet; L Tiret; B Balkau; P Guicheney
Journal:  Eur J Hum Genet       Date:  2007-05-30       Impact factor: 4.246

5.  An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval.

Authors:  Ashish Kapoor; Rajesh B Sekar; Nancy F Hansen; Karen Fox-Talbot; Michael Morley; Vasyl Pihur; Sumantra Chatterjee; Jeffrey Brandimarto; Christine S Moravec; Sara L Pulit; Arne Pfeufer; Jim Mullikin; Mark Ross; Eric D Green; David Bentley; Christopher Newton-Cheh; Eric Boerwinkle; Gordon F Tomaselli; Thomas P Cappola; Dan E Arking; Marc K Halushka; Aravinda Chakravarti
Journal:  Am J Hum Genet       Date:  2014-05-22       Impact factor: 11.025

6.  Influence of genetic modifiers on sudden cardiac death cases.

Authors:  Tina Jenewein; Thomas Neumann; Damir Erkapic; Malte Kuniss; Marcel A Verhoff; Gerhard Thiel; Silke Kauferstein
Journal:  Int J Legal Med       Date:  2017-12-06       Impact factor: 2.686

7.  Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study.

Authors:  Sumeet S Chugh; Kyndaron Reinier; Tejwant Singh; Audrey Uy-Evanado; Carmen Socoteanu; Dawn Peters; Ronald Mariani; Karen Gunson; Jonathan Jui
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

8.  Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation.

Authors:  Stefan Kääb; Dawood Darbar; Charlotte van Noord; Josée Dupuis; Arne Pfeufer; Christopher Newton-Cheh; Renate Schnabel; Seiko Makino; Moritz F Sinner; Prince J Kannankeril; Britt M Beckmann; Subbarao Choudry; Brian S Donahue; Jan Heeringa; Siegfried Perz; Kathryn L Lunetta; Martin G Larson; Daniel Levy; Calum A MacRae; Jeremy N Ruskin; Annette Wacker; Albert Schömig; H-Erich Wichmann; Gerhard Steinbeck; Thomas Meitinger; André G Uitterlinden; Jacqueline C M Witteman; Dan M Roden; Emelia J Benjamin; Patrick T Ellinor
Journal:  Eur Heart J       Date:  2009-01-13       Impact factor: 29.983

9.  Positive selection at codon 38 of the human KCNE1 (= minK) gene and sporadic absence of 38Ser-coding mRNAs in Gly38Ser heterozygotes.

Authors:  Holger Herlyn; Ulrich Zechner; Franz Oswald; Arne Pfeufer; Hans Zischler; Thomas Haaf
Journal:  BMC Evol Biol       Date:  2009-08-06       Impact factor: 3.260

10.  Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies.

Authors:  Ilja M Nolte; Chris Wallace; Stephen J Newhouse; Daryl Waggott; Jingyuan Fu; Nicole Soranzo; Rhian Gwilliam; Panos Deloukas; Irina Savelieva; Dongling Zheng; Chrysoula Dalageorgou; Martin Farrall; Nilesh J Samani; John Connell; Morris Brown; Anna Dominiczak; Mark Lathrop; Eleftheria Zeggini; Louise V Wain; Christopher Newton-Cheh; Mark Eijgelsheim; Kenneth Rice; Paul I W de Bakker; Arne Pfeufer; Serena Sanna; Dan E Arking; Folkert W Asselbergs; Tim D Spector; Nicholas D Carter; Steve Jeffery; Martin Tobin; Mark Caulfield; Harold Snieder; Andrew D Paterson; Patricia B Munroe; Yalda Jamshidi
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.